Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FEMY NASDAQ:HIND NASDAQ:TNON NASDAQ:ZJYL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFEMYFemasys$4.17$6.39$3.50▼$22.20$12.59M-2.1362,009 shs65,372 shsHINDVyome$2.30$2.16$1.75▼$18.60$16.15M1.4919,404 shs18,222 shsTNONTenon Medical$0.29$0.64$0.27▼$2.48$3.46M1.3617.72 million shs71.23 million shsZJYLJin Medical International$1.96$2.35$1.64▼$17.18$15.35M7.3431,304 shs9,434 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFEMYFemasys-4.14%+15.83%-43.85%-52.53%-78.05%HINDVyome+2.22%+9.00%0.00%+7.98%+229,999,900.00%TNONTenon Medical-10.34%-40.67%-53.26%-59.15%-70.18%ZJYLJin Medical International+3.70%-15.52%-39.69%+5.95%-84.70%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFEMYFemasys$4.17$6.39$3.50▼$22.20$12.59M-2.1362,009 shs65,372 shsHINDVyome$2.30$2.16$1.75▼$18.60$16.15M1.4919,404 shs18,222 shsTNONTenon Medical$0.29$0.64$0.27▼$2.48$3.46M1.3617.72 million shs71.23 million shsZJYLJin Medical International$1.96$2.35$1.64▼$17.18$15.35M7.3431,304 shs9,434 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFEMYFemasys-4.14%+15.83%-43.85%-52.53%-78.05%HINDVyome+2.22%+9.00%0.00%+7.98%+229,999,900.00%TNONTenon Medical-10.34%-40.67%-53.26%-59.15%-70.18%ZJYLJin Medical International+3.70%-15.52%-39.69%+5.95%-84.70%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFEMYFemasys 2.50Moderate Buy$106.672,457.95% UpsideHINDVyome 2.40Hold$15.00552.17% UpsideTNONTenon Medical 2.00HoldN/AN/AZJYLJin Medical International 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest TNON, HIND, ZJYL, and FEMY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/29/2026ZJYLJin Medical International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)6/3/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/18/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/13/2026TNONTenon Medical Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/6/2026HINDVyome Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/4/2026HINDVyome Litchfield Hills ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy5/1/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/1/2026HINDVyome Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)4/20/2026TNONTenon Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/15/2026ZJYLJin Medical International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)(Data available from 7/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFEMYFemasys$2.29M5.50N/AN/A$2.01 per share2.07HINDVyome$320K50.46N/AN/A$0.67 per share3.43TNONTenon Medical$3.94M0.88N/AN/A$0.18 per share1.62ZJYLJin Medical International$20.69M0.74$0.19 per share10.32$3.78 per share0.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFEMYFemasys-$18.63M-$5.40N/AN/AN/A-521.97%-258.08%-73.72%8/12/2026 (Estimated)HINDVyome-$10.26M-$12.27N/AN/AN/AN/A-203.92%-134.16%N/ATNONTenon Medical-$12.56M-$1.29N/AN/AN/A-270.09%-907.60%-110.17%8/12/2026 (Estimated)ZJYLJin Medical International$1.19MN/AN/AN/AN/AN/AN/AN/AN/ALatest TNON, HIND, ZJYL, and FEMY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026HINDVyomeN/A-$0.15N/A-$0.15N/A$0.03 million5/12/2026Q1 2026TNONTenon Medical-$0.3050-$0.31-$0.0050-$0.31$1.30 million$1.38 million5/8/2026Q1 2026FEMYFemasys-$1.3334$0.0980+$1.4314N/A$0.77 million$0.42 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthFEMYFemasysN/AN/AN/AN/AN/AHINDVyomeN/AN/AN/AN/AN/ATNONTenon MedicalN/AN/AN/AN/AN/AZJYLJin Medical InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFEMYFemasys0.533.911.98HINDVyomeN/A4.274.27TNONTenon MedicalN/A1.030.92ZJYLJin Medical InternationalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFEMYFemasys65.27%HINDVyome22.06%TNONTenon Medical22.74%ZJYLJin Medical InternationalN/AInsider OwnershipCompanyInsider OwnershipFEMYFemasys7.75%HINDVyome33.00%TNONTenon Medical17.71%ZJYLJin Medical InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFEMYFemasys303.02 million2.79 millionNot OptionableHINDVyome507.02 million4.70 millionN/ATNONTenon Medical811.85 million9.75 millionNot OptionableZJYLJin Medical International2457.83 millionN/ANot OptionableTNON, HIND, ZJYL, and FEMY HeadlinesRecent News About These CompaniesJin Medical International Ltd. (NASDAQ:ZJYL) Short Interest UpdateJuly 3 at 4:21 AM | americanbankingnews.comJin Medical International Ltd - Ordinary Shares - Class AJuly 1 at 6:10 PM | money.usnews.comJin Medical Plans Major VIE Acquisition and Governance Restructuring Ahead of July 2026 EGMJune 29, 2026 | tipranks.comReviewing Jin Medical International (NASDAQ:ZJYL) & Haemonetics (NYSE:HAE)June 27, 2026 | americanbankingnews.comJin Medical International (NASDAQ:ZJYL) Shares Down 2% - What's Next?June 23, 2026 | americanbankingnews.comJin Medical International Replaces Audit Alliance With Enrome as Independent AuditorJune 4, 2026 | tipranks.comJin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share SplitApril 10, 2026 | theglobeandmail.comJin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price RequirementApril 7, 2026 | prnewswire.comJin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance InitiativeMarch 11, 2026 | prnewswire.comJin Medical Shareholders Approve Dual-Class Structure and Conditional Reverse SplitsFebruary 7, 2026 | theglobeandmail.comJin Medical CEO Fireside ChatFebruary 5, 2026 | prnewswire.comJin Medical to Host February 1 Fireside Chat as It Revamps Corporate WebsiteJanuary 28, 2026 | tipranks.comJin Medical International Ltd. To Host Management Fireside ChatJanuary 26, 2026 | prnewswire.comJin Medical Sets April Launch for High-Capacity Chuzhou Mobility Device PlantJanuary 22, 2026 | tipranks.comJin Medical Announces the Official Commencement Date of Chuzhou FacilityJanuary 22, 2026 | prnewswire.comJin Medical International Ltd. Management Plans For Fireside ChatJanuary 21, 2026 | finance.yahoo.comJin Medical International Ltd. to Host Fireside Chat on Strategic Priorities and Capital Structure on February 1, 2026January 21, 2026 | quiverquant.comQJin Medical Calls January 30 EGM to Restructure Share Capital and Adopt New Equity PlanJanuary 8, 2026 | tipranks.comJin Medical International (NASDAQ:ZJYL) Trading Down 4.6% – Should You Sell?November 22, 2025 | defenseworld.netDAre Jin Medical International Ltd.'s (NASDAQ:ZJYL) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?October 5, 2025 | uk.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026SpaceX Rings the Bell and Shatters Every RecordBy Jeffrey Neal Johnson | June 12, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 2026What's Behind the Social Media Controversy Surrounding IonQ?By Nathan Reiff | June 15, 2026Coke's $10B India IPO Plan Pops the Top on Hidden ValueBy Jeffrey Neal Johnson | June 3, 2026TNON, HIND, ZJYL, and FEMY Company DescriptionsFemasys NASDAQ:FEMY$4.17 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$4.18 +0.01 (+0.36%) As of 07/2/2026 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.Vyome NASDAQ:HIND$2.30 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$2.17 -0.13 (-5.43%) As of 07/2/2026 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.Tenon Medical NASDAQ:TNON$0.29 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$0.28 -0.01 (-3.87%) As of 07/2/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.Jin Medical International NASDAQ:ZJYL$1.96 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$1.97 +0.01 (+0.51%) As of 07/2/2026 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon SanDisk’s Volatility May Be Telling Bulls What They Want to Hear Why the Comcast Spin-Off Won't Fix What's Actually Broken Shorting the Grid: Bloom Energy’s $25B AI Power Play Why Kroger's Giant Eagle Deal Could Change Everything SMRs Spark a Chain Reaction for Nano Nuclear 3 Dividend ETFs Built for Stability in a Volatile Market Agility Robotics’ SPAC Deal Opens a Rare Door Into Humanoid AI Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
